{"transactions":[{"id":1680615,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":95250,"kind":"person","name":"DENNY GEORGE P III","position":1,"cik":"0001234956","reported_name":"DENNY GEORGE P III","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}}],"security":"Warrants to Purchase Common Stock","published_at":"2024-01-11T19:14:17.000Z","date":"2023-12-29","kind":"purchase","planned":false,"acquired":true,"shares":3913526,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Denny Family Partners II, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Denny Family Partners II, LLC (\"DFP\") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which DFP acquired (i) $107,622 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the \"Notes\") and (ii) 3,913,526 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share (\"Common Stock\"), at an exercise price of $0.055 per share (the \"Warrants\"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Denny Family Partners II, LLC (\"DFP\") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which DFP acquired (i) $107,622 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the \"Notes\") and (ii) 3,913,526 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share (\"Common Stock\"), at an exercise price of $0.055 per share (the \"Warrants\"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of the securities held by Denny Family Partners II, LLC except to the extent of his pecuniary interest therein."}],"balance_after":3913526,"derivative":{"exercise_price":0.055,"exercise_date":"2023-12-29","expiration_date":"2028-12-29","underlying":"Common Stock","underlying_shares":3913526},"source":{"system":"sec-edgar","filing":"0001104659-24-003414","document":"tm243228-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1234956/000110465924003414/tm243228-2_4seq1.xml","form_type":"4"}},{"id":1680614,"issuer":{"id":94670,"kind":"organization","name":"Comera Life Sciences Holdings, Inc.","symbol":"CMRA"},"owners":[{"id":95250,"kind":"person","name":"DENNY GEORGE P III","position":1,"cik":"0001234956","reported_name":"DENNY GEORGE P III","relationship":{"director":false,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"Member of 10% owner group"}}],"security":"12.0% Senior Secured Convertible Notes","published_at":"2024-01-11T19:14:17.000Z","date":"2023-12-29","kind":"purchase","planned":false,"acquired":true,"price":107622,"reported_value":107622,"ownership":{"direct":false,"nature":"By Denny Family Partners II, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Denny Family Partners II, LLC (\"DFP\") entered into a Securities Purchase Agreement with the Issuer on December 29, 2023, pursuant to which DFP acquired (i) $107,622 principal amount of the Issuer's 12.0% Senior Secured Convertible Notes (the \"Notes\") and (ii) 3,913,526 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.0001 per share (\"Common Stock\"), at an exercise price of $0.055 per share (the \"Warrants\"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The reporting person disclaims beneficial ownership of the securities held by Denny Family Partners II, LLC except to the extent of his pecuniary interest therein."}],"derivative":{"exercise_price":0.055,"exercise_date":"2023-12-29","expiration_date":"2024-12-29","underlying":"Common Stock","underlying_shares":1956763},"source":{"system":"sec-edgar","filing":"0001104659-24-003414","document":"tm243228-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1234956/000110465924003414/tm243228-2_4seq1.xml","form_type":"4"}},{"id":2595570,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":95250,"kind":"person","name":"DENNY GEORGE P III","position":1,"cik":"0001234956","reported_name":"DENNY GEORGE P III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T17:38:46.000Z","date":"2021-07-14","kind":"purchase","acquired":true,"shares":1,"price":11.99,"value":11.99,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":3,"source":{"system":"sec-edgar","filing":"0001062993-21-007818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/748592/000106299321007818/form4.xml","form_type":"4"}},{"id":2595569,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":95250,"kind":"person","name":"DENNY GEORGE P III","position":1,"cik":"0001234956","reported_name":"DENNY GEORGE P III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T17:38:46.000Z","date":"2021-07-09","kind":"purchase","acquired":true,"shares":1,"price":14.11,"value":14.11,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":2,"source":{"system":"sec-edgar","filing":"0001062993-21-007818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/748592/000106299321007818/form4.xml","form_type":"4"}},{"id":2595568,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":95250,"kind":"person","name":"DENNY GEORGE P III","position":1,"cik":"0001234956","reported_name":"DENNY GEORGE P III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T17:38:46.000Z","date":"2021-07-08","kind":"purchase","acquired":true,"shares":1,"price":14.35,"value":14.35,"ownership":{"direct":false,"nature":"By Spouse"},"balance_after":1,"source":{"system":"sec-edgar","filing":"0001062993-21-007818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/748592/000106299321007818/form4.xml","form_type":"4"}},{"id":2595567,"issuer":{"id":8278,"kind":"organization","name":"Ernexa Therapeutics Inc.","symbol":"ERNA"},"owners":[{"id":95250,"kind":"person","name":"DENNY GEORGE P III","position":1,"cik":"0001234956","reported_name":"DENNY GEORGE P III","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-08-20T17:38:46.000Z","date":"2021-07-06","kind":"sale","acquired":false,"shares":75000,"price":16.0625,"value":1204687.5,"ownership":{"direct":false,"nature":"By Denny Family Partners II, LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale by Denny Family Partners II, LLC of BTX Common Stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 3 shares, with the purchase of 3 shares of BTX Common Stock by the reporting person's spouse, also reported herein.  The reporting person has agreed to pay to BTX, upon settlement of the sale, $8.78, representing the full amount of the profit realized in connection with the short-swing transaction, less transaction costs."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.41, inclusive. The reporting person undertakes to provide to Brooklyn ImmunoTherapeutics, Inc., any security holder of Brooklyn ImmunoTherapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote 2."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The reporting person disclaims beneficial ownership of the shares held by Denny Family Partners II, LLC except to the extent of his pecuniary interest therein."}],"balance_after":4775117,"source":{"system":"sec-edgar","filing":"0001062993-21-007818","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/748592/000106299321007818/form4.xml","form_type":"4"}}]}